The L5178Y/tk(+/-) mouse lymphoma specific gene and chromosomal mutations assay: A phase III report of the U.S. environmental protection agency Gene-Tox program

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 394, Issue 1-3, 1997, Pages 177-303

  Mitchell, A D ^a   Auletta, A E ^b   Clive, D ^e   Kirby, P E ^c   Moore, M M ^b   Myhr, B C ^d  

^a Genesys Research   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c SITEK Research Laboratories   (United States)

^d UK   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; BIOASSAY; DIAGNOSTIC VALUE; ENVIRONMENTAL PROTECTION; GENE LOCUS; GENOTOXICITY; LYMPHOMA; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHROMOSOME ABERRATIONS; LEUKEMIA L5178; MICE; MUTATION; REFERENCE STANDARDS; THYMIDINE KINASE; TUMOR CELLS, CULTURED; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

ANIMALIA; RODENTIA;

EID: 0031474758     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(97)00115-0     Document Type: Article

References (154)

1. Aaron C.S., Petry T.W., Thilagar A., Kumaroo P.V., Kirby P. Comparative mutagenicity testing of bropirimine. 1. Induction of chromosome aberrations in CHO cells is not reflected in induction of mutation at the TK locus of L5178Y cells Mutation Res. 252:1991;221-228.
2. Amacher D.E., Paillet S., Ray V.A. Point Mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. 1. Application to genetic toxicological testing Mutation Res. 64:1979;391-406.
3. Amacher D.E., Paillet S.C., Turner G.N., Ray V.A., Salsburg D.S. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation. Mutation Res. 72:1980;447-474.
4. +/- mouse lymphoma cells. Mutation Res. 89:1981;311-320.
5. Amacher D.E., Ellis J.H. Jr., Joyce A.J., Muehlbauer P.A., Turner G.N., Wahrenburg M.G., Holden H.E., Ray V.A. Preclinical toxicology studies with azithromycin: genetic toxicology evaluation. Mutation Res. 300:1993;79-90.
6. +/- cells. Mutation Res. 78:1980;279-288.
7. +/- cell mutation assay. Cancer Lett. 14:1981;151-158.
8. Amacher D.E., Paillet S.C. The activation of procarcinogens to mutagens by cultured rat hepatocytes in the L5178Y/TK mutation assay. Mutation Res. 113:1983;77-88.
9. Amacher D.E., Turner G.N. Promutagen activation by rodent-liver postmitochondrial fractions in the L5178Y/TK cell mutation assay. Mutation Res. 74:1980;485-501.
10. Amacher D.E., Turner G.N. Mutagenic evaluation of carcinogens and non-carcinogens in the L5178Y/TK assay utilizing postmitochondrial fractions (S9) from normal rat liver. Mutation Res. 97:1982;49-65.
11. Amacher D.E., Turner G.N. The mutagenicity of 5-azacytidine and other inhibitors of replicative DNA synthesis in the L5178Y mouse lymphoma cells. Mutation Res. 176:1987;123-131.
12. Anderson B.E., Zeiger E., Resnick M.A., Shelby M.D., Gulati D.K., Ivett J.L., Loveday K.S. Chromosome aberrations and sister chromatid exchange tests with 42 chemicals. Environ. Mol. Mutagen. 16(S18):1990;55-138.
13. Applegate, M.L., Hozier, J.C., 1987. On the complexity of mutagenic events at the mouse lymphoma tk locus. In: Moore, M.M. et al. (Eds.), Mammalian Cell Mutagenesis. Banbury Report 28. Cold Spring Harbor Laboratory Press, New York, pp. 213-224.
14. Applegate M.L., Moore M.M., Broder C.B., Burrell A., Juhn G., Kaswek K.L., Lin P.-F., Wadhams A., Hozier J.C. Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc. Natl. Acad. Sci. USA. 87:1990;51-55.
15. Arce G.T., Allen J.W., Doerr C.L., Elmore E., Hatch G.G., Moore M.M., Sharief Y., Grunberger D., Nesnow S. Relationships between benzo[a]pyrene-DNA adduct levels and genotoxic effects in mammalian cells. Cancer Res. 47:1987;3388-3395.
16. Bendele A.M., Neal S.B., Oberly T.J., Thompson C.Z., Bewsey B.J., Hill L.E., Rexroat M.A., Carlton W.W., Probst G.S. Evaluation of ochratoxin A for mutagenicity in a battery of bacterial and mammalian cell assays. Food Chem. Toxicol. 23:1985;911-918.
17. Biles R.W., Piper C.E. Mutagenicity of chloropropanol in a genetic screening battery. Fund. Appl. Toxicol. 3:1983;27-33.
18. +/- assay supplemented with formaldehyde dehydrogenase. In Vitro Toxicol. 4:1991;121-132.
19. Blazak W.F., Stewart B.E., Galperin I., Allen K.L., Rudd C.J., Mitchell A.D., Caspary W.J. Chromosome analysis of trifluorothymidine-resistant L5178Y mouse lymphoma cell colonies. Environ. Mutagen. 8:1986;229-240.
20. Brusick D. Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations. Environ. Mutagen. 8:1986;879-886.
21. Brusick, D., Matheson, D., 1976. Mutagenic evaluation of 1,1-dimethylhydrazine, methylhydrazine and N-phenyl-alpha-naphthylamine. In: Proceedings of the 7th Annual Conference on Environmental Toxicology, pp. 108-129.
22. Brusick D., Matheson D., Jagannath D., Braude M., Brockman H., Hung C. Genetic screening of compounds used in drug abuse treatment. II. Methadone. Drug Chem. Toxicol. 4:1981;1-18.
23. Brusick D., Matheson D., Jagannath D., Braude M., Brockman H., Hung C. Genetic screening of compounds used in drug abuse treatment. III. LAAM Drug Chem. Toxicol. 4:1981;19-35.
24. Brusick D., Myhr B., Galloway S., Rundell J., Jagannath D.R., Tarka S. Genotoxicity of theobromine in a series of short-term assays. Mutation Res. 169:1986;105-114.
25. +/- assays. Mutation Res. 189:1987;223-261.
26. +/- assays. Mutation Res. 155:1985;17-25.
27. +/- assay. Environ. Mol. Mutagen. 17:1991;264-271.
28. Carver J.H., Bootman J., Cimino M.C., Esber H.J., Kirby P., Kirkhart B., Wong Z.A., MacGregor J.A. Genotoxic potential of acephate technical: in vitro and in vivo effects. Toxicology. 35:1985;125-142.
29. Casciano D.A., Talaska G., Clive D. The potent hepatocarcinogen methapyrilene induces mutations in L5178Y mouse lymphoma cells in the apparent absence of DNA adduct formation. Mutation Res. 263:1991;127-132.
30. Caspary W.J., Langenbach R., Penman B.W., Crespi C., Myhr B.C., Mitchell A.D. The mutagenic activity of selected compounds at the TK locus: rodent vs. human cells. Mutation Res. 196:1988;61-81.
31. Caspary W.J., Myhr B. Mutagenicity of methylisocyanate and its reaction products to cultured mammalian cells. Mutation Res. 174:1986;285-293.
32. Caspary W.J., Myhr B., Bowers L., McGregor D., Riach C., Brown A. Mutagenic activity of fluorides in mouse lymphoma cells. Mutation Res. 187:1987;165-180.
33. Clay P., Cross M.F. Microwell mutation assays: Evaluation of ethylmethanesulphonate, benzo[a]pyrene and benzidine using the tk locus in L5178Y mouse lymphoma cells. Mutagenesis. 5(Suppl.):1990;45-54.
34. +/- mutagenicity assay. In: Moore, M.M. et al. (Eds.) Mammalian Cell Mutagenesis. Banbury Report 28. Cold Spring Harbor Laboratory Press, New York, pp. 25-36.
35. +/- mouse lymphoma cells to detect single gene and viable chromosome mutations: valuation and relevance to mutagen and carcinogen screening. In: Williams, G.M. et al. (Eds), The Predictive Value of Short-Term Screening Tests in Carcinogenicity Evaluation. Elsevier/North Holland Biomedical Press, New York, pp. 103-123.
36. Clive D., Flamm W.G., Machesko M.R., Bernheim N.J. A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutation Res. 16:1972;77-87.
37. -/- mutants. Mutation Res. 253:1991;73-82.
38. +/- mouse lymphoma mutagen assay system. Mutation Res. 59:1979;61-108.
39. Clive D., McCuen R., Spector J.F.S., Piper C., Mavournin K.H. Specific gene mutations in L5178Y cells in culture. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutation Res. 115:1983;225-251.
40. Clive D., Spector J.F.S. Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutation Res. 31:1975;17-29.
41. Clive D., Turner N.T., Hozier J., Batson A.G., Tucker W.E. Jr. Preclinical toxicology studies with acyclovir: genetic toxicity tests. Fund. Appl. Toxicol. 3:1983;587-602.
42. +/-) locus of the mouse lymphoma assay. Mutagenesis. 3:1988;83-87.
43. Cole J., Arlett C.F., Green M.H.L., Lowe J., Muriel W. A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells. Mutation Res. 111:1983;371-386.
44. Cole J., Diot M.-C., Richmond F.N., Bridges B.A. Comparative induction of gene mutations and chromosome damage by 1-methoxy-1,3,5-cycloheptatriene (MCHT). 2. Results using L5178Y mouse lymphoma cells to detect both gene and chromosome damage; validation with ionizing radiation, methyl methanesulphonate, ethyl methanesulphonate and benzo[a]pyrene Mutation Res. 230:1990;81-91.
45. +/(3.7.2c)] mouse lymphoma cells. Mutagenesis. 1:1986;157-167.
46. +/--3.7.2C mouse lymphoma cells: measurement of mutations to ouabain, 6-thioguanine and trifluorothymidine resistance, and the induction of micronuclei. Mutation Res. 253:1991;55-62.
47. Coppinger W.J., Brennan S.A., Carver J.H., Thompson E.D. Locus specificity of mutagenicity of 2,4,-diaminotoluene in both L5178Y mouse lymphoma and AT3-2 Chinese hamster ovary cells. Mutation Res. 135:1984;115-123.
48. Dearfield K.L., Millis C.S., Harrington-Brock K., Doerr C.L., Moore M.M. Analysis of the genotoxicity of nine acrylate/methacrylate compounds in L5178Y mouse lymphoma cells. Mutagenesis. 4:1989;381-393.
49. +/--3.7.2C mouse lymphoma cells. Mutation Res. 187:1987;141-149.
50. DeMarini D.M., Brock K.H., Doerr C.L., Moore M.M. Mutagenicity of actinomycin D in mammalian cells due to clastogenic effects. Mutation Res. 192:1987;151-155.
51. +/--3.7.2 cells. Mutation Res. 204:1988;323-328.
52. DeMarini D.M., Doerr C.L., Meyer M.K., Brock K.H., Hozier J., Moore M.M. Mutagenicity of m-AMSA and o-AMSA in mammalian cells due to clastogenic mechanism: Possible role of topoisomerase. Mutagenesis. 2:1987;349-355.
53. Doerr C.L., Harrington-Brock K., Moore M.M. Micronucleus, chromosome aberration, and small-colony TK mutant analysis to quantitate chromosomal damage in L5178Y mouse lymphoma cells. Mutation Res. 222:1989;191-203.
54. Dunkel V.C., Rogers-Back A.M., Lawlor T.E., Harbell J.W., Cameron T.P. Mutagenicity of some alkyl nitrites used as recreational drugs. Environ. Mol. Mutagen. 14:1989;115-122.
55. Dunkel V.C., San R.H.C., Harbell J.W., Seifried H.E., Cameron T.P. Evaluation of the mutagenicity of an N-nitroso contaminant of the sunscreen padimate O: N-Nitroso-N-methyl-p-aminobenzoic acid, 2-ethylhexyl ester (NPABAO). Environ. Mol. Mutagen. 20:1992;188-198.
56. Dunnick, J.K., 1986. NTP Technical Report on the toxicology and carcinogenesis studies of dimethyl methylphosphonate (TR323).
57. +/- cells following treatment with benzidine and 4,4′-diaminoterphenyl in vitro. In: Parry, J.M., Arlett, C.F. (Eds.), Comparative Genetic Toxicology: The Second UKEMS Collaborative Study. MacMillan, London, pp. 327-332.
58. Edgar D.H. The mutagenic potency of 4 agents at the thymidine kinase locus in mouse lymphoma L5178Y cells in vitro: Effects of exposure time. Mutation Res. 157:1985;199-204.
59. Frantz C.N., Malling H.V. Bromodeoxyuridine resistance induced in mouse lymphoma cells by microsomal activation of dimethylnitrosamine. J. Toxicol. Environ. Health. 2:1976;179-187.
60. Freshney, R.I., 1983. Culture of Animal Cells. A Manual of Basic Technique. Alan R. Liss, New York, 295 pp.
61. Fung V.A., Cameron T.P., Hughes T.J., Kirby P.E., Dunkel V.C. Mutagenic activity of some coffee flavor ingredients. Mutation Res. 204:1988;219-228.
62. Galloway S.M., Armstrong M.J., Reuben C., Colman S., Brown B., Cannon C., Bloom A.D., Nakamura F., Ahmed M., Duk S., Rimpo J., Margolin B.H., Resnick M.A., Anderson B., Zeiger E. Chromosome aberrations and sister chromatid exchanges in Chinese Hamster Ovary cells: Evaluations of 108 chemicals. Environ. Mol. Mutagen. 10(S10):1987;1-175.
63. Garriott M.L., Adams E.R., Probst G.S., Emmerson J.L., Oberly T.J., Kindig D.E.F., Neal S.B., Bewsey B.J., Rexroat M.A. Genotoxicity studies on the preemergence herbicide trifluralin. Mutation Res. 260:1991;187-193.
64. Gold A., Nesnow S., Moore M., Garland H., Curtis G., Howard B., Graham D., Eisenstadt E. Mutagenesis and morphological transformation of mammalian cells by a non-bay-region polycyclic cyclopenta[cd]pyrene and its 3,4-oxide. Cancer Res. 40:1980;4482-4484.
65. Hammond B.G., Barbee S.J., Wheeler A.G., Cascieri T. Absence of mutagenic activity for monosodium cyanurate. Fund. Appl. Toxicol. 5:1985;655-664.
66. Harrington-Brock K., Parker L., Doerr C., Cimino M.C., Moore M.M. Analysis of the genotoxicity of anthraquinone dyes in the mouse lymphoma assay. Mutagenesis. 6:1991;35-46.
67. Haseman J.K., Clark A.-M. Carcinogenicity results for 114 laboratory animal studies used to assess the predictivity of four in vitro genetic toxicity assays for rodent carcinogenicity. Environ. Mol. Mutagen. 16(18):1990;15-31.
68. Henderson L., Ransome S., Brabbs C., Tinner A., Davies S. Induction of mutations in mouse lymphoma L5178Y cells by ethyl methanesulphonate, benzidine and benzo[a]pyrene. Mutagenesis. 5(Suppl.):1990;27-34.
69. Hinderer R.K., Myhr B., Jagannath D.R., Galloway S.M., Mann S.W., Riddle J.C., Brusick D.J. Mutagenic evaluations of four rubber accelerators in a battery of in vitro mutagenic assays. Environ. Mutagen. 5:1983;193-215.
70. +/--3.7.2C cell line. Mutation Res. 105:1982;451-456.
71. -/- mutants early in their clonal history. Ann. N.Y. Acad. Sci. 107:1985;423-425.
72. Ivett J.L., Brown B.M., Rodgers C., Anderson B.E., Resnick M.A., Zeiger E. Chromosomal aberrations and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. IV. Results with 15 chemicals. Environ. Mol. Mutagen. 14:1989;165-197.
73. Jones, D.C.L., Simmon, V.F., Mortelmans, K.E., Mitchell, A.D., Evans, E.L., Jotz, M.M., Riccio, E.S., Robinson, D.E., Kirkhart, B.A., 1984. In vitro and in vivo mutagenicity studies of environmental chemicals, SRI Report, EPA Contract No. 68-02-2947.
74. Jotz M.M., Mitchell A.D. Effects of 20 coded chemicals on the forward mutation frequency at the thymidine kinase locus in L5178Y mouse lymphoma cells. Prog. Mutat. Res. 1:1981;580-593.
75. Kirby P.E., Pizzarello R.F., Lawlor T.E., Haworth S.R., Hodgson J.R. Evaluation of di-(2-ethylhexyl)phthalate and its major metabolites in the Ames test and L5178Y mouse lymphoma mutagenicity assay. Environ. Mutagen. 5:1983;657-663.
76. Kirwin C.J., LeBlanc J.V., Thomas W.C., Haworth S.R., Kirby P.E., Tilgar A., Bowman J.T., Brusick D.J. Evaluation of the genetic activity of industrially produced carbon black. J. Toxicol. Environ. Health. 7:1981;973-989.
77. Kligerman A.D., Moore M.M., Erexson G.L., Brock K.H., Doerr C.L., Allen J.W., Nesnow S. Genotoxicity studies of benz[l]aceanthrylene. Cancer Lett. 31:1986;123-131.
78. Knaap A.G.A.C., Kramers P.G.N., Voogd C.E., Bergkamp W.G.M., Groot M.G., Langebroek P.G., Mout H.C.A., van der Stel J.J., Verharen H.W. Mutagenic activity of acrylamide in eukaryotic systems but not in bacteria. Mutagenesis. 3:1988;263-268.
79. Kramers P.G.N., Voogd C.E., Knaap A.G.A.C., van der Heijden C.A. Mutagenicity of methyl bromide in a series of short-term tests. Mutation Res. 155:1985;41-47.
80. Lee Y.J., Caspary W.J. Mathematical model of L5178Y mouse lymphoma forward mutation assay. Mutation Res. 113:1983;417-430.
81. Lin G.H.Y., Brusick D.J. Mutagenicity studies on FD and C red no. 3. Mutagenesis. 1:1986;253-259.
82. Loveday K.S., Lugo M.H., Resnick M.A., Anderson B.E., Zeiger E. Chromosomal aberrations and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. II. Results with 20 chemicals Environ. Mol. Mutagen. 13:1989;60-94.
83. MacGregor J.T., Gould D.H., Mitchell A.D., Sterling G.P. Mutagenicity tests of diflubenzuron in the micronucleus test in mice, the L5178Y mouse lymphoma forward mutation assay, and the Ames Salmonella reverse mutation test. Mutation Res. 66:1979;45-53.
84. +/- mouse lymphoma mutation assay. Environ. Mol. Mutagen. 16:1990;311-319.
85. Mavournin K.H., Blakey D.H., Cimino M.C., Salamone M.F., Heddle J.A. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutation Res. 239:1990;29-80.
86. - mouse lymphoma forward mutation assay. II: 18 coded chemicals. Environ. Mol. Mutagen. 11:1988;91-118.
87. - mouse lymphoma cell forward mutation assay. III: 72 coded chemicals. Environ. Mol. Mutagen. 12:1988;85-154.
88. McGregor D., Brown A.G., Cattanach P., Edwards I., McBride D., Riach C., Shepherd W., Caspary W.J. Responses of the L5178Y mouse lymphoma forward mutation assay. V. Gases and vapors Environ. Mol. Mutagen. 17:1991;122-129.
89. McGregor D.B., Brown A.G., Cattanach P., Shepherd W., Riach C., Daston D.S., Caspary W.J. TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine. Carcinogenesis. 10:1989;2003-2008.
90. McGregor D.B., Brown A.G., Howgate S., McBride D., Riach C., Caspary W.J. Responses of the L5178Y mouse lymphoma cell forward mutation assay. V: 27 Coded chemicals Environ. Mol. Mutagen. 17:1991;196-219.
91. McGregor D.B., Edwards I., Riach C.G., Cattanach P., Martin R., Mitchell A., Caspary W.J. Studies of an S9-based metabolic activation system used in the mouse lymphoma L5178Y cell mutation assay. Mutagenesis. 3:1988;485-490.
92. - mouse lymphoma cell forward mutation assay to coded chemicals. I: Results for nine compounds Environ. Mutagen. 9:1987;143-160.
93. McGregor D.B., Riach C.G., Brown A., Edwards I., Reynolds D., West K., Willington S. Reactivity of catecholamines and related substances in the mouse lymphoma L5178Y cell assay for mutagens. Environ. Mol. Mutagen. 11:1988;523-544.
94. McKee R.H., Lington A.W., Traul K.A. An evaluation of the genotoxic potential of di-isononyl adipate. Environ. Mutagen. 8:1986;817-827.
95. McKee R.H., Phillips R.D., Traul K.A. The genetic toxicity of 1,2-dibromo-3-chloropropane, 1,2-dibromo-3-chloro-2-methylpropane, and 1,2,3-tribromo-2-methylpropane. Cell Biol. Toxicol. 3:1987;391-406.
96. +/- mutation, DNA single-strand break, and Balb/c 3T3 chemical transformation assays. Mutation Res. 88:1981;317-324.
97. Meyer M., Brock K., Lawrence K., Casto B., Moore M.M. Evaluation of the effect of agar on the results obtained in the L5178Y mouse lymphoma assay. Environ. Mutagen. 8:1986;727-740.
98. Mitchell, A.D., Auletta, A.E., Clive, D., Kirby, P.E., Moore, M.M., Myhr, B.C. (submitted). Check your premises: A comparison of the NTP and Gene-Tox evaluations of the utility of the mouse lymphoma assay for predicting rodent carcinogenicity.
99. Mitchell, A.D. Deahl, J.T., Caspary, W.J. (submitted). Reassessment of the clastogenicity of chemicals that the NTP evaluated as negative in the CHO aberration assay and positive in the mouse lymphoma assay.
100. Mitchell A.D., Myhr B.C., Rudd C.J., Caspary W.J., Dunkel V.C. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Methods used and chemicals evaluated. Environ. Mutagen. 12(S13):1988;1-18.
101. Mitchell A.D., Rudd C.J., Caspary W.J. Evaluation of the L5178Y lymphoma cell mutagenesis assay: Intralaboratory results for sixty-three coded chemicals tested at SRI International. Environ. Mol. Mutagen. 12(S13):1988;37-101.
102. Moldeus P., Nordenskjold M., Bolcsfoldi G., Eiche A., Haglund U., Lambert B. Genetic toxicology of dopamine. Mutation Res. 124:1983;9-24.
103. +/- mouse lymphoma assay, and in vivo sister chromatid exchange analysis in mice. Environ. Mol. Mutagen. 12:1988;219-233.
104. Moore M.M., Amtower A., Doerr C., Brock K.H., Dearfield K.L. Mutagenicity and clastogenicity of acrylamide in L5178Y mouse lymphoma cells. Environ. Mutagen. 9:1987;261-267.
105. Moore M.M., Amtower A., Doerr C.L., Brock K.H., Dearfield K.L. Genotoxicity of acrylic acid, methyl acrylate, ethyl acrylate, methyl methacrylate and ethyl methacrylate in L5178Y mouse lymphoma cells. Environ. Mol. Mutagen. 11:1988;49-63.
106. +/- mouse lymphoma cells. Environ. Mol. Mutagen. 12:1988;265-268.
107. +/--3.7.2C mouse lymphoma cells. Mutation Res. 191:1987;183-188.
108. +/--3.7.2C mouse lymphoma cells by the clastogen ellipticine. Environ. Mutagen. 9:1987;161-179.
109. +/- mouse lymphoma cells at varying times post-treatment. Environ. Mutagen. 4:1982;499-519.
110. +/- mouse lymphoma cells. Mutation Res. 85:1981;363-378.
111. Moore M.M., Harrington-Brock K., Doerr C.L., Dearfield K.L. Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci. Mutagenesis. 4:1989;394-403.
112. 6-hydroxyadenine (AHA) to mouse lymphoma and CHO cells. Mutation Res. 253:1991;63-71.
113. +/- mouse lymphoma cells in RPMI-1640 medium. Mutation Res. 104:1982;287-294.
114. Myhr B., Bowers L., Caspary W.J. Assays for the induction of gene mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells in culture. Prog. Mutation Res. 5:1985;555-568.
115. Myhr B.C., Caspary W.J. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Results of assay of 63 coded chemicals tested at Litton Bionetics, Inc. Environ. Mol. Mutagen. 12(S13):1988;103-194.
116. Myhr B.C., Caspary W.J. Chemical mutagenesis at the Thymidine kinase locus in L5178Y mouse lymphoma cells: Results for 31 coded compounds in the National Toxicology Program, NTP data for 31 compounds. Environ. Mol. Mutagen. 18:1991;51-83.
117. Myhr B., McGregor D., Bowers L., Riach C., Brown A.G., Edwards I., McBride D., Martin R., Caspary W.J. L5178Y Mouse lymphoma cell mutation assay results with 41 compounds. Environ. Mol. Mutagen. 16(S18):1990;138-167.
118. Nesnow S., Argus M., Bergman H., Chu K., Frith C., Helmes T., McGaughy R., Ray V., Slaga T.J., Tennant R., Weisburger E. Chemical carcinogens. A review and analysis of the literature of selected chemicals and the establishment of the Gene-Tox Carcinogen Data Base. Mutation Res. 185:1986;1-195.
119. +/- mouse lymphoma forward mutation assay using 42 chemicals. Mutation Res. 125:1984;291-306.
120. +/- forward mutation assay. Mutation Res. 241:1990;151-159.
121. +/- mutation assays using suspension treatment and soft agar cloning: Results for 10 chemicals. Cell Biol. Toxicol. 9:1993;243-258.
122. Oberly T.J., Piper C.E., McDonald D.S. Mutagenicity of metal salts in the L5178Y mouse lymphoma assay. J. Toxicol. Environ. Health. 9:1982;367-376.
123. +/- mouse lymphoma assay.
124. O'Donoghue J.L., Haworth S.R., Curren R.D., Kirby P.E., Lawlor T., Moran E.J., Phillips R.D., Putnam D.L., Rogers-Back A.M., Slesinski R.S., Thilagar A. Mutagenicity studies on ketone solvents: Methyl ethyl ketone, methyl isobutyl ketone, and isophorone. Mutation Res. 206:1988;149-161.
125. Oglesby L.A., Harrington Brock K., Moore M.M. Induced hepatocytes as a metabolic activation system for the mouse-lymphoma assay. Mutation Res. 223:1989;295-302.
126. Oldham J.W., Sedor D.D., Preston R.F., Newman D., Paulson J.D. Genetic toxicity evaluation of McN-5195: A novel analgesic. Cell Biol. Toxicol. 4:1988;357-370.
127. Oshiro Y., Piper C.E., Soelter S.G., Balwierz P.S., Garriott M.L. Genotoxic properties of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU). Fund. Appl. Toxicol. 18:1992;491-498.
128. Palmer K.A., Denunzio A., Green S. The mutagenic assay of some hair dye components, using the thymidine kinase locus of L5178Y mouse lymphoma cells. J. Env. Path. Toxicol. 1:1977;87-91.
129. Palmer K.A., Sheu C.W., Green S. Mutagenicity studies of R-amino salt, a metabolite of amaranth (FD and C Red No. 2), in mouse lymphoma cells heterozygous at the thymidine kinase locus and in the rat dominant lethal test. Food Cosmet. Toxicol. 17:1979;5-9.
130. Paschin Y.V. Mutagenicity of maleic acid hydrazide for the TK locus of mouse lymphoma cells. Mutation Res. 91:1981;359-362.
131. Purves D., Harvey C., Tweats D., Lumley C.E. Genotoxicity testing: current practices and strategies used by the pharmaceutical industry. Mutagenesis. 10:1995;297-312.
132. +/- mouse lymphoma mutagenicity assay using standardized and non-standardized protocols. Mutagenesis. 5(Suppl.):1990;35-44.
133. Richold M. The genotoxicity of trenbolone, a synthetic steroid. Arch. Toxicol. 61:1988;249-258.
134. +/- assay. Mutation Res. 204:1988;149-162.
135. Rudd, C.J., Mitchell, A.D., 1983. L5178Y mouse lymphoma cell forward mutation assays of 24 coded compounds, SRI project LSU-3447 reports for EPA contract No. 68-02-3702.
136. +/- mouse lymphoma cells. Environ. Mutagen. 9(S8):1987;92.
137. Sandhu S.S., Waters M.D., Mortelmans K.E., Evans E.L., Jost M.M., Mitchell A.D., Kasica V. Evaluation of diallate and triallate herbicides for genotoxic effects in a battery of in vitro and short-term in vivo tests. Mutation Res. 136:1984;173-183.
138. Sarkar F.H., Radcliff G., Callewaert D.M., Marnett L.J., Eling T., Daston D.S., Caspary W.J. Mutagenic response of mouse lymphoma cells after activation of benzidine and 2-aminofluorene with purified prostaglandin H synthase. Mutation Res. 242:1990;319-328.
139. Scribner H.E., McCarthy K.L., Moss J.N., Hayes A.W., Smith J.M., Cifone M.A., Probst G.S., Valencia R. The genetic toxicology of Kathon biocide, a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one. Mutation Res. 118:1983;129-152.
140. Searle A.G., Peters J., Lyon M.F., Hall J.G., Evans E.P., Edwards J.H., Buckle V.J. Chromosome maps of man and mouse. IV. Ann. Hum. Genet. 53:1989;89-140.
141. Styles J.A., Richardson C.R., Callander R.D., Cross M.F., Bennett I.P., Longstaff E. Activity of bromochlorodifluoromethane (BCF) in three mutation tests. Mutation Res. 142:1985;187-192.
142. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., Minor R. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science. 236:1987;933-941.
143. Thompson E.D., Aardema M.J., LeBoeuf R.A. Lack of genotoxicity with acrylate polymers in five short-term mutagenicity assays. Environ. Mol. Mutagen. 14:1989;98-106.
144. Thompson E.D., Coppinger W.J., Piper C.E., McCarroll N., Oberly T.J., Robinson D. Mutagenicity of alkyl glycidyl ethers in three short-term assays. Mutation Res. 90:1981;213-231.
145. Thompson E.D., Coppinger W.J., Valencia R., Iavicoli J. Mutagenicity testing of diethylene glycol monobutyl ether. Environ. Health Perspect. 57:1984;105-112.
146. Thompson E.D., McDermott J.A., Zerkle T.B., Skare J.A., Evans B.L.B., Cody D.B. Genotoxicity of zinc in 4 short-term mutagenicity assays. Mutation Res. 223:1989;267-272.
147. Thompson E.D., Seymour J.L., Aardema M.J., LeBoeuf R.A., Evans B.L.B., Cody D.B. Lack of genotoxicity of cross-linked acrylate polymers in four short-term genotoxicity assays. Environ. Mol. Mutagen. 18:1991;184-199.
148. Thornton S.C., Diamond L., Hite M., Baird W.M. The effect of liver homogenate (S20) concentration on polycyclic aromatic hydrocarbon activation and mutation induction in the L5178Y mouse lymphoma mutation assay. Mutation Res. 106:1982;101-112.
149. -/- mouse lymphoma assay. In: Kilbey et al. (Eds.), Handbook of Mutagenicity Test Procedures, 2nd ed. Elsevier, Amsterdam, pp. 239-268.
150. +/- mouse lymphoma assay. Mutation Res. 189:1987;285-297.
151. +/- mouse lymphoma cells by 4-dimethylaminoazobenzene and 4-cyanodimethylaniline. In: Parry, J.M., Arlett, C.F. (Eds.), Comparative Genetic Toxicology: The Second UKEMS Collaborative Study. MacMillan, London, pp. 319-326.
152. Wangenheim J., Bolcsfoldi G. Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds. Mutagenesis. 3:1988;193-205.
153. Waters M.D., Bergman H.B., Nesnow S. The genetic toxicology of Gene-Tox non-carcinogens. Mutation Res. 205:1988;139-182.
154. Zeiger E., Haseman J.K., Shelby M.D., Margolin B.H., Tennant R.W. Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: Confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen. 16(S18):1990;1-14.